TMC Life Sciences Berhad (0101.KL)

MYR 0.49

(-1.01%)

Annual Income Statements

(In MYR)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 346.41 Million 311.44 Million 243.77 Million 201.02 Million 184.08 Million 194.97 Million
Cost of Revenue 234.53 Million 90.09 Million 75.78 Million 66.76 Million 137.98 Million 57.37 Million
Gross Profit 111.87 Million 221.35 Million 167.98 Million 134.26 Million 46.1 Million 137.6 Million
Operating Expenses 56.68 Million 178.36 Million 137.91 Million 109.39 Million 29.43 Million 107.62 Million
Selling, General and Administrative Expenses - 59.26 Million 43.47 Million 31.41 Million 30.03 Million 34.02 Million
Research and Development Expenses - - - - - -
Other Expenses 56.68 Million 3.15 Million 1.84 Million 865 Thousand 600 Thousand 866 Thousand
Cost and Expenses 291.22 Million 268.46 Million 213.69 Million 176.16 Million 167.41 Million 165 Million
Operating Income 55.19 Million 49.38 Million 33.91 Million 27.91 Million 16.67 Million 38.23 Million
Interest Expense 10.25 Million 9.4 Million 2.1 Million 441 Thousand 386.4 Thousand 85 Thousand
Income Tax Expense 11.97 Million 1.63 Million -9.2 Million 7.41 Million 6.17 Million 17.23 Million
Earnings before Tax 52.62 Million 40.89 Million 32.18 Million 27.67 Million 22.1 Million 38.15 Million
Net Income 40.64 Million 39.25 Million 41.38 Million 20.25 Million 15.93 Million 20.91 Million
Earnings Per Share Basic 0.02 0.02 0.02 0.01 0.01 0.01
Earnings Per Share Diluted 0.02 0.02 0.02 0.01 0.01 0.01
Weighted Average Shares Outstanding 1.74 Billion 1.74 Billion 1.74 Billion 1.74 Billion 1.74 Billion 1.73 Billion
Weighted Average Shares Outstanding (Diluted) 1.74 Billion 1.74 Billion 1.74 Billion 1.74 Billion 1.74 Billion 1.73 Billion
Gross Margin 0.32 0.71 0.69 0.67 0.25 0.71
EBIT Margin 0.26 0.24 0.20 0.20 0.16 0.25
Profit Margin 0.12 0.13 0.17 0.10 0.09 0.11
EBITDA 90.78 Million 76.3 Million 50.13 Million 41.13 Million 28.6 Million 49.44 Million
Earnings Before Tax Margin 0.16 0.16 0.14 0.14 0.09 0.20

Income Statement Charts